STOCK TITAN

Vanguard disaggregates holdings for Evolus (NASDAQ: EOLS) after internal realignment

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group amended its Schedule 13G to report that it beneficially owns 0 shares (0%) of Evolus Inc. common stock following an internal realignment. The filing cites the SEC Release No. 34-39538 disaggregation guidance and states certain Vanguard subsidiaries will report separately after the realignment.

The amendment clarifies voting and dispositive powers as 0 and notes the change in reporting structure that led to separate beneficial‑ownership filings by former Vanguard divisions.

Positive

  • None.

Negative

  • None.

Insights

Amendment confirms disaggregated reporting and zero beneficial ownership.

The filing records 0 shares and 0% ownership and cites an internal realignment effective January 12, 2026 under SEC Release No. 34-39538. This is an administrative change where related Vanguard entities will report separately.

Impact is procedural: cash‑flow treatment and trading intent are not disclosed. Subsequent filings from Vanguard subsidiaries may show holdings if applicable.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What does The Vanguard Group's Schedule 13G/A say about EOLS ownership?

The filing states The Vanguard Group beneficially owns 0 shares (0%) of Evolus Inc. common stock. It attributes the change to an internal realignment and disaggregated reporting under SEC Release No. 34-39538 effective January 12, 2026.

Why did Vanguard report zero ownership of Evolus (EOLS)?

Vanguard reports zero because an internal realignment caused subsidiaries to report separately. The filing cites SEC Release No. 34-39538, stating certain Vanguard divisions will now file disaggregated beneficial‑ownership reports.

Does this Schedule 13G/A show Vanguard sold Evolus shares?

No—this amendment is a reporting change showing 0 shares beneficially owned; it does not state any sale or transaction. The filing explains a reallocation of reporting responsibility among Vanguard entities.

Who signed the amendment reporting Vanguard's position in EOLS?

The amendment was signed by Ashley Grim, titled Head of Global Fund Administration. The signature block lists the date 03/26/2026 beneath the signatory's name and title.

Will other Vanguard entities report Evolus holdings after this amendment?

The filing indicates certain subsidiaries or business divisions will report separately under the disaggregation guidance. Subsequent Schedule 13 filings by those Vanguard entities may disclose any holdings if present.